Citraconimide
Citraconimide is a 3-methylmaleimide derivative. Citraconimide has thiol affinity and can undergo highly regioselective addition with a variety of alkyl thiols. Citraconimide derivatives show growth inhibitory activity against HeLa cells. Citraconimide can be modified by N-substitution, halogenation and other reactions for use in bioactive molecule design and drug development research[1].
Product Specifications
CAS Number
[1072-87-3]
Product Name Alternative
3-Methylmaleimide; 2-Methylmaleimide
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Drug Intermediate
Related Pathways
Others
Field of Research
Others
Purity
96.84
Smiles
O=C(N1)C(C)=CC1=O
Molecular Formula
C5H5NO2
Molecular Weight
111.10
Precautions
H315, H319, H335
References & Citations
[1]Earl, R.A., et al. Chemical investigations of citraconimide†. Journal of Heterocyclic Chemistry, 15: 1479-1483.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Mapk13, CT (Mapk13, Serk4, Mitogen-activated protein kinase 13, Mitogen-activated protein kinase p38 delta, Stress-activated protein kinase 4) (MaxLight 550) discontinued
TremL4 (NM_001163796) Mouse Tagged ORF Clone Lentiviral Particle
Vascular Endothelial Growth Factor C (VEGFC), Recombinant, Human, His-Tag, SUMO-Tag
